Navigation Links
Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
Date:11/4/2008

TORRANCE (Nov. 4, 2008) In the first-ever study of its kind, a team led by researchers at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) report in November's Psychiatric Services journal that Spanish-speaking Hispanics took longer to respond to medication for depression and were less likely to go into remission than English-speaking Hispanics.

Using data from the nation's largest real-world clinical study of depression, the researchers found the Spanish-speaking participants in the study were older and were more likely to be women than the English speakers. The Spanish speakers also had less education and lower income, more medical issues and were more likely than English speakers to be seen in primary care than psychiatric clinics.

"Once we adjusted for these differences in their socioeconomic status, both groups responded about the same to medication for depression," said Ira Lesser, M.D., a LA BioMed investigator who authored the report. "These results are important for clinicians and patients to be aware that Spanish-speaking Hispanics with depression who come from lower social economic groups may need more than medication for depression."

Funded by the National Institute of Mental Health, the study surveyed the treatment records of 195 Spanish-speaking and English-speaking Hispanics who had sought care at the Los Angeles and San Diego sites from among the more than 4,000 patients who participated in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, the nation's largest real-world study of depression.

"Hispanics are the nation's largest ethnic minority and its fastest-growing population group," said Dr. Lesser. "As clinicians ourselves, we always are seeking information on the best treatments for our patients, taking into account the differences among them."

Hispanics comprise about 15% of the U.S. population, and 40% are born outside the
'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
2. Response Biomedical Closes $5.1 Million Financing
3. A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
4. Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference
5. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
6. Response Biomedical Announces Insider Participation in Current Financing
7. Hurricane Ike: World Vision Readies Supplies, Staff, Volunteers for Response
8. Monitoring immune responses in disease
9. Gustav: World Vision Teams Assist Evacuees in Jackson and Dallas, Prepare Response
10. Immune Response May Hinder Stem Cell Treatments
11. Study sees need for standardized evaluation of antibody response to HIV-1

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9 Sutter Health, a family of docto... service providers, is donating $255,000 to food b...l food banks will share the quarter-million-dollar...les of thousands of families across the north stat...tnering with and supporting charitable programs an...
(Date:11/9/2009)...swire/ -- The Churchill Centre today announced t... J.W. "Bill" Marriott for his lifelong commitment ...rket practices and fostering an open and transpare...ive his award at a ceremony and dinner on Tuesday,...otel. ,, "This is a testament to how Bill Marr...
(Date:11/9/2009)...wswire/ -- Tracy Anderson, trainer to Gwyneth Palt...e hosting two events at her LA studio this week th...ng awaited Nutritional Meal Plan and Delivery Serv...eanse and Lifestyle Menu. She will also be teachi...hod of cardio and muscle structure work. Both eve...
(Date:11/9/2009)...gement, study finds , , MONDAY, Nov. 9 (...for left atrial enlargement, which increases the r...w study shows. , Atrial fibrillation is the mos...ythm or heartbeat). , Researchers analyzed dat...y who were followed for 10 years. The study author...
(Date:11/9/2009)...ing Genetic Variance Across the World is Critical ... (Vocus) November 9, 2009 -- Underst...narily valuable when analyzing and interpreting sc...dy that scanned the genomes of 4,000 people throug...Drs. Chao Tian and Michael F. Seldin of the Univer...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:News from the November/December Issue of Molecular Medicine 2
...tes its 50th anniversary this holiday season, MIN...t,Minneapolis-based Courage Center, announces its ...ard collection. This season, Courage Cards is,cele...Rapids, Wis. -- Nature,s Peace, an,original waterc...
...fit the Cancer Center at Children,s Hospital of ...PHIA, Sept. 8 aloft(SM) hotels, Starwood Hotels,a...festyle brand, which,opened in Philadelphia on 8.8..., A Philadelphia suburb and Havertown native, Han...
... Terrell Samuels, CEO of The,Marketing Doctor LLC,...r,exclusive roster ... fertility specialist Dr. Pe...ls. Dr. Saadat is a well-respected fertility,speci...es, internet, radio, television networks, reality ...
...ildren wielding club while playing away from cours...ay News) -- Although rare, golf-related eye injure...y. , The researchers looked at six boys and five ...ercent) by a golf ball," wrote Dr. Eric M. Hink, o...
...e brain shrinkage, study shows , , MONDAY,...h low levels of vitamin B12 seem to be at increase...esearch suggests. , Brain atrophy is associated wi...levels of B12 actually cause brain atrophy, they...
...The U.S. Department of,Veterans Affairs (VA) annou...g veterans, voter registration activities, with pa...ommunity living centers, domiciliaries and,patient...ups to its hospitals and outpatient clinics to ass...
Other Medicine News:Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008 2Health News:Kids' Eye Injuries From Golf Clubs Rare But Severe 2Health News:Vitamin B12 Key to Aging Brain 2Health News:Vitamin B12 Key to Aging Brain 3Health News:VA Clarifies Voter Registration Regulations 2
(Date:11/9/2009)...v. 9 /PRNewswire-Asia-FirstCall/ -- American Orien...any" or "AOBO"), a pharmaceutical,company dedicate...ufacture and,commercialization of a broad range of...s, today announced that it plans to release third ... 16, 2009, after the market closes. , The...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
(Date:11/9/2009)...9, 2009 Arena Pharmaceut...ial results for the third quarter ended September ...locable to common stockholders in the third quarte...mpared to a net loss allocable to common stockhold... or $0.76 per share, and a net loss allocable to c...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Customers Design Reid Supply 26apos 3Bs New Web Site 50846 1Customers Design Reid Supply 26apos 3Bs New Web Site 50846 2Customers Design Reid Supply 26apos 3Bs New Web Site 50846 3Customers Design Reid Supply 26apos 3Bs New Web Site 50846 4Customers Design Reid Supply 26apos 3Bs New Web Site 50846 5MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 1SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 3
...t and Phase 1b Combination Clinical Trials ...y, SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,...ata Saturday from two,clinical trials of the compa...595), including updated results of a Phase 1 trial...sed or refractory patients with acute,myeloid leuk...
...Pharmaceuticals,Inc. (Amex: ANX ) today provided ... Phase 2b clinical trial of CoFactor for the treat...verall survival results in this,study have been re...fluorouracil) arm demonstrating a 14 day improveme...5-FU arm., "In the Phase 2b study, CoFactor was d...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
Utility & Splinter Forceps #H
Evisceration Disposible Sizers
Straight Iris Forceps
Semkin Forceps with stops
Medicine Products: